Brian Michael Bonnell - 01 Sep 2026 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Reporting relationship: Chief Financial Officer
Issuer ticker: ICUI
Reported as of: 01 Sep 2026
Net transaction value: -$1,116,675
SEC form: 4
Accepted by SEC: 01 Sep 2026, 17:21:57 UTC
Prior SEC filing: 31 Aug 2026
Source filing: View source filing
Reporting owner signature: By: Paula Darbyshire, Attorney-in-Fact For: Brian Bonnell

Key filing fact

Brian Michael Bonnell filed Form 4 for ICU MEDICAL INC/DE (ICUI) on 01 Sep 2026.

Key facts

This page summarizes Brian Michael Bonnell's Form 4 filing for ICU MEDICAL INC/DE (ICUI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Sep 2026, 17:21.

Change

Previous filing in this sequence was filed on 31 Aug 2026.
Current net transaction value: -$1,116,675.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001804831 Primary reporting owner

Bonnell Brian Michael

Relationship: Chief Financial Officer
Address: 951 CALLE AMANECER, SAN CLEMENTE
Signature: By: Paula Darbyshire, Attorney-in-Fact For: Brian Bonnell
Signature date: 01 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICUI transaction

Common Stock

Sale

Transaction value: $1,116,675
Shares: -6,381
Change %: -10%
Price: $175.00
Shares after: 56,062
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.

Footnote F2

All shares sold were sold at the exact price disclosed.